Revenue (Tables)

12 Months Ended

Dec. 31, 2024

Revenue from Contract with Customer [Abstract]

Schedule of revenue disaggregated by Group, end customer geographical location and timing of recognition

The following table presents the Company’s revenue by End Customer Geography for the years ended December 31 (in millions):


	2024		2023		2022
United States	$	938.5	$	777.7	$	696.1
Germany		310.7		281.5		247.4
Rest of Europe		873.0		699.7		591.9
China		471.2		528.1		396.5
Rest of Asia Pacific		518.5		460.9		408.4
Other		254.5		216.6		190.4
Total revenue	$	3,366.4	$	2,964.5	$	2,530.7

The following table presents revenue for the Company recognized at a point in time versus over time for the years ended December 31 (in millions):


	2024		2023		2022
Revenue recognized at a point in time	$	2,894.9	$	2,575.3	$	2,204.7
Revenue recognized over time		471.5		389.2		326.0
Total revenue	$	3,366.4	$	2,964.5	$	2,530.7

Schedule of contract balances associated with revenue

For the years ended December 31 (in millions) the following balances were associated with revenue:


	2024		2023
Contract assets	$	105.2	$	85.8
Contract liabilities (a)		538.2		491.4
Remaining performance obligations (b)	$	2,090.4	$	2,226.7

Approximately $348.6 million of the contract liability balance on December 31, 2023, was recognized as revenue during the year ended December 31, 2024.

Bruker’s mix of remaining performance obligations, or backlog, consists of firm orders under non-cancelable purchase orders received from customers and the timing of revenue recognition can vary significantly due to a variety of factors. Bruker manufactures innovative scientific instruments and diagnostic solutions which can result in varying production and installation timing due to components, customization, manufacturing, assembly, testing processes, and customer site availability or readiness. Our expected completion of performance obligation can vary from year to year based on these and other factors. As a result, backlog on any particular date can be indicative of our short-term revenue performance but is not necessarily a reliable indicator of long-term revenue performance. The Company will recognize revenues for these performance obligations as they are satisfied, the majority of which is expected to occur within the next twelve months.